Syndax Pharmaceuticals Inc
NASDAQ:SNDX

Watchlist Manager
Syndax Pharmaceuticals Inc Logo
Syndax Pharmaceuticals Inc
NASDAQ:SNDX
Watchlist
Price: 20.88 USD 2.5% Market Closed
Market Cap: 1.8B USD

Wall Street
Price Targets

SNDX Price Targets Summary
Syndax Pharmaceuticals Inc

Wall Street analysts forecast SNDX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SNDX is 40.09 USD with a low forecast of 27.27 USD and a high forecast of 58.8 USD.

Lowest
Price Target
27.27 USD
31% Upside
Average
Price Target
40.09 USD
92% Upside
Highest
Price Target
58.8 USD
182% Upside
Syndax Pharmaceuticals Inc Competitors:
Price Targets
BNTX
BioNTech SE
49% Upside
BCYC
Bicycle Therapeutics PLC
200% Upside
2696
Shanghai Henlius Biotech Inc
69% Upside
688177
Bio-Thera Solutions Ltd
61% Upside
87S
Roivant Sciences Ltd
13% Upside
MRNA
Moderna Inc
27% Upside
TLX
Telix Pharmaceuticals Ltd
125% Upside
BAVA
Bavarian Nordic A/S
37% Upside

Revenue
Forecast

Revenue Estimate
Syndax Pharmaceuticals Inc

The compound annual growth rate of Syndax Pharmaceuticals Inc's revenue for the next 4 years is 138%.

N/A
Past Growth
138%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Syndax Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Syndax Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-59%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SNDX's stock price target?
Price Target
40.09 USD

According to Wall Street analysts, the average 1-year price target for SNDX is 40.09 USD with a low forecast of 27.27 USD and a high forecast of 58.8 USD.

What is Syndax Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
138%

The compound annual growth rate of Syndax Pharmaceuticals Inc's revenue for the next 4 years is 138%.

Back to Top